## Clinical Context: Orthostatic Hypotension in Parkinson's Disease This patient has **autonomic dysfunction** secondary to Parkinson's disease, characterized by impaired sympathetic outflow and baroreceptor reflex failure. The marked orthostatic drop (70 mmHg systolic) with syncope indicates severe autonomic neuropathy. ## Pathophysiology of Orthostatic Hypotension **Key Point:** Normal orthostatic compensation requires: 1. Baroreceptor sensing of postural BP drop 2. Sympathetic activation → norepinephrine release 3. Vasoconstriction and increased heart rate 4. Restoration of cerebral perfusion In Parkinson's disease, **autonomic neurons degenerate**, blocking steps 2–3. ## Management Hierarchy for Orthostatic Hypotension ```mermaid flowchart TD A["Orthostatic Hypotension<br/>with Syncope"]:::outcome --> B["Step 1: Non-pharmacological<br/>Salt loading, fluids, compression stockings<br/>Supine sleeping, gradual position changes"]:::action B --> C{"Symptoms controlled?"}:::decision C -->|Yes| D["Continue conservative measures"]:::action C -->|No| E["Step 2: Pharmacotherapy<br/>Midodrine α1-agonist"]:::action E --> F{"Response adequate?"}:::decision F -->|Yes| G["Continue midodrine + non-pharm"]:::action F -->|No| H["Consider fludrocortisone or<br/>pyridostigmine as adjuncts"]:::action ``` ## Why Midodrine Is the Correct Choice | Feature | Midodrine | Why It Works | |---------|-----------|---------------| | Mechanism | Selective α1-adrenergic agonist | Directly stimulates vascular smooth muscle; bypasses defective sympathetic neurons | | Onset | 1 hour; peak 1–2 hours | Rapid symptom relief | | Duration | 2–4 hours per dose | Typical dosing: 5–10 mg TID | | Safety in Parkinson's | Safe; does not worsen tremor or rigidity | Unlike dopaminergic agents | | Efficacy | Increases BP by 15–30 mmHg supine | Restores orthostatic tolerance | **High-Yield:** Midodrine is the **first-line pharmacotherapy** for orthostatic hypotension in autonomic failure because it: - Directly activates α1-receptors on blood vessels - Does not depend on intact sympathetic neurons - Has rapid onset and predictable duration - Is safe in Parkinson's disease ## Non-Pharmacological Measures (Essential First Step) **Clinical Pearl:** Always start with lifestyle modifications: 1. **Increase salt intake** to 10–12 g/day (expands intravascular volume) 2. **Compression stockings** (30–40 mmHg) to reduce venous pooling 3. **Adequate hydration** (2–3 L/day) 4. **Supine sleeping** (prevents nocturnal polyuria and volume loss) 5. **Gradual position changes** (sit up, wait 1 min, then stand) 6. **Avoid triggers:** hot environments, large meals, straining ## Why Other Options Are Incorrect **Warning:** Common mistakes in this scenario: 1. **Increasing levodopa** (Option A): - Levodopa itself can worsen orthostatic hypotension in advanced Parkinson's - Does not restore sympathetic function in autonomic failure - Dopaminergic stimulation does not replace lost norepinephrine neurons 2. **IV saline + antihypertensives** (Option C): - Counterintuitive: antihypertensives worsen orthostatic hypotension - IV saline is acute but not sustainable long-term - Supine hypertension (160/95 mmHg) is common in autonomic failure and should NOT be treated aggressively 3. **Carotid sinus massage** (Option D): - Diagnostic test, not therapeutic - Can cause syncope in this patient - Does not address the underlying sympathetic deficit ## Key Distinction: Supine vs. Orthostatic BP **Mnemonic: "SUPINE HYPER, ORTHO HYPO"** — In autonomic failure: - Supine BP is elevated (160/95) due to loss of normal sympathetic tone regulation - Orthostatic BP is severely low (90/50) due to failure of sympathetic compensation - This paradox is pathognomonic for autonomic neuropathy - Do NOT treat supine hypertension aggressively; focus on orthostatic symptoms [cite:Harrison 21e Ch 418; Robbins 10e Ch 28]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.